Plasma Rich Platelets Therapy (PRP)

Platelet-rich plasma (PRP) is an autologous blood product that contains a high concentration of platelets and leucocytes, which are fundamental fibroblast proliferation agents.

PRP involves the preparation of autologous and biologically safe blood products that contain concentrated leucocytes and platelets, which releases growth factors, cytokines and chemokines and subsequently influences tissue regenerative cells such as fibroblasts.

EmCyte PurePRP® is a highly sophisticated cell separating apparatus designed uniquely to concentrate regenerative cellular components. EmCyte PurePRP® clinical use is vastly becoming widespread due to its efficacy in Skin Regeneration, Hair Restoration, Sexual Health, MSK and Orthopaedic applications, and Pain Medicine.

What sets EmCyte apart is the unique processing features of PurePRP®.

PurePRP remains the only system on the market that can provide clinical platelet concentrations of greater than 7 x baseline in 7 mL of PRP ( 1.4 million platelets/µL) while simultaneously removing 99% of RBC’s and 98% of inflammatory neutrophils. Overall, within 7 mL of PurePRP® an average of 10 billion deliverable platelets are obtained. High volumes of deliverable platelets enhance the volumetric activity of growth factors. Thus, promoting tissue repair. Furthermore, PurePRP® remains effective in cytokine activity and antimicrobial performance because it is the only system that can do all of the previous functions while maintaining a high concentration and yield of mononuclear cells, needed for the chemical stimulus to attract and direct regenerative cells to damaged tissue. Again, the key is the physiology of Emcyte PurePRP®, which is very different from other systems and unlike common tubes. An Emcyte PurePRP® face treatment requires one kit whereas the tube systems require 3-4 tubes (and are still very low in platelet retrieval). .

In addition to the unique processing feature of Emcyte PurePRP®, it remains a completely closed system during all steps of processing. It is never open to air, as soon as you detach your syringe, the self-sealing swabbable valve automatically closes. Emcyte PurePRP® processes in 6.5 minutes, which is the shortest of all viable tabletop systems.